Leerink Partners Cut Price Target on Cardiovascular Systems (CSII) Following Disappointing 2Q and 3Q Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
Cardiovascular Systems Reports Fiscal 2016 Second-Quarter Financial Results
January 21, 2016 4:05 PM ESTConference Call Scheduled for Today, January 21, 2016, at 3:45 PM CT (4:45 PM ET)
Revenues of $41.4 million were 3% below the guidance range due to continued effects of the sales force transition Gross margin increased to 80.5%, primarily benefiting from lower unit costs Net loss of $(0.47) per share was favorable to guidance, primarily as a result of cost reductions LIBERTY 360° enrollment nears completion, demographic data to be presented at ISET as a late-breaking presentation COAST 30-day... More